Prevencio has assembled a seasoned senior management group with a wealth of relevant experience, a history of working together as a team, and a track record of success in developing biomedical technologies and starting, funding, and managing early-stage companies. The company has an outstanding relationship with the University of Pittsburgh consisting of internationally-recognized scientists, cardiologists and clinicians, and a Board of Directors composed of business leaders with many years of experience managing and directing early-stage “life science” companies. The Prevencio founding management team possesses over 100 years of experience in the biotechnology arena, genomic and proteomics, marketing and finance.
Click here for Management.